H. Lundbeck AS (FRA:LDBA) Cyclically Adjusted PB Ratio: (As of Sep. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:LDBA H. Lundbeck AS FRA:LDBA
79 GF Score
Price €5.70
GF Value €5.20
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is H. Lundbeck AS Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


H. Lundbeck AS  (FRA:LDBA) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


H. Lundbeck AS Cyclically Adjusted PB Ratio Related Terms


H. Lundbeck AS Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for H. Lundbeck AS's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

H. Lundbeck AS Cyclically Adjusted PB Ratio Chart

H. Lundbeck AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 1.29 1.60 1.96 1.88

H. Lundbeck AS Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.71 2.11 1.97 1.79 1.87

FRA:LDBA vs ZTS, UTHR, VTRS: Cyclically Adjusted PB Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, H. Lundbeck AS's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


H. Lundbeck AS Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, H. Lundbeck AS's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where H. Lundbeck AS's Cyclically Adjusted PB Ratio falls into.


FRA:LDBA
79GF Score
H. Lundbeck AS FRA:LDBA
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

H. Lundbeck AS Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

H. Lundbeck AS's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, H. Lundbeck AS's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=3.622/122.9500*122.9500
=3.622

Current CPI (Jun. 2026) = 122.9500.

H. Lundbeck AS Quarterly Data

Book Value per Share CPI Adj_Book
201609 1.556 100.200 1.909
201612 1.652 100.300 2.025
201703 1.671 101.200 2.030
201706 1.812 101.200 2.201
201709 1.949 101.800 2.354
201712 2.059 101.300 2.499
201803 1.964 101.700 2.374
201806 2.121 102.300 2.549
201809 2.284 102.400 2.742
201812 2.402 102.100 2.893
201903 2.143 102.900 2.561
201906 2.275 102.900 2.718
201909 2.421 102.900 2.893
201912 2.826 102.900 3.377
202003 2.739 103.300 3.260
202006 2.803 103.200 3.339
202009 2.827 103.500 3.358
202012 2.869 103.400 3.411
202103 2.914 104.300 3.435
202106 2.968 105.000 3.475
202109 3.060 105.800 3.556
202112 3.092 106.600 3.566
202203 3.120 109.900 3.490
202206 2.651 113.600 2.869
202209 2.831 116.400 2.990
202212 2.813 115.900 2.984
202303 2.835 117.300 2.972
202306 2.918 116.400 3.082
202309 3.013 117.400 3.155
202312 2.981 116.700 3.141
202403 3.032 118.400 3.149
202406 3.139 118.500 3.257
202409 3.223 118.900 3.333
202412 3.383 118.900 3.498
202503 3.323 120.200 3.399
202506 3.271 120.700 3.332
202509 3.399 121.600 3.437
202512 3.361 121.180 3.410
202603 3.457 121.670 3.493
202606 3.622 122.950 3.622

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is H. Lundbeck AS (FRA:LDBA) Overvalued in 2026?

Based on GuruFocus' analysis, H. Lundbeck AS stock appears to be overvalued. The current stock price of €5.70 is trading 9.6% above its estimated GF Value™ of €5.20. GuruFocus considers H. Lundbeck AS to be Fairly Valued.

Key valuation signals for FRA:LDBA:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: €5.20 vs. price of €5.70 (9.6% above fair value)
  • GF Score™: 79/100 with 5 warning signs

No single metric tells the full story. See the FRA:LDBA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


H. Lundbeck AS Business Description

Address Ottiliavej 9, Valby, DNK, 2500
Lundbeck is a Denmark-based pharmaceutical firm that focuses on the development and commercialization of central nervous system drugs including antidepressants, antipsychotics, and antiepileptic products. The company's portfolio includes Abilify Maintena and Rexulti for psychosis, Brintellix/Trintellix for depression, Northera for Parkinson's disease symptoms, Sabril and Onfi for seizures, and Vyepti for migraine prevention. Most of the company's sales are derived in North America, followed by Asia and Europe.
79GF Score

Get the complete analysis for FRA:LDBA

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.70
Price
€5.20
GF Value